White House releases statement on at-home COVID-19 testing, potential cost implications - Bim Group

White House releases statement on at-home COVID-19 testing, potential cost implications

SOURCE: UnitedHealthcare

READ TIME: 2 MINUTES

On Dec. 2, 2021, the White House released a statement announcing several actions to fight COVID-19, including requiring commercial health plans to cover COVID-19 at-home tests – approved or authorized by the Food and Drug Administration (FDA) – without cost-sharing. The White House has directed the Tri-Agencies (Departments of Health and Human Services, Labor and the Treasury) to issue guidance implementing this policy by Jan. 15, 2022.

The following information has been conveyed through the statement and press announcement:

  • The requirements will likely apply to fully insured, level-funded and self-funded group plans, including grandfathered and transitional relief business and business through the Exchanges.
  • The Administration preliminarily indicated the coverage requirements would not apply retroactively and would only provide coverage for diagnostic tests, as the current requirement stipulates.
  • Any requirements would likely extend through the Public Health Emergency.

UnitedHealthcare regulatory, clinical, actuarial, operations and COVID-19 testing teams are working to address and respond to the guidance when it is released.

The guidance is expected to impact 2022 health care spending. For example, at an average cost of $25 for 2 tests, and 6 tests submitted per member in 2022, the additional cost per member would be $75.

UnitedHealthcare will provide input to the Administration on how to best implement this new policy in a manner that balances access with affordability and patient safety.

Please contact your broker or UnitedHealthcare representative if you have questions or would like to learn more about advocacy efforts.

Recent Insights

April 7, 2025
News

Impact of Executive Order on Sex and Gender Identity

On January 20, 2025, the Trump administration issued an executive order redefining the terms sex, gender identity, and related concepts as they pertain to federal law and policy. These changes will affect compliance requirements across various employee benefit provisions and related regulations. Key Provisions of the Executive Order Revised Definitions The Executive Order revised the […]
Read more
April 7, 2025
HIPAA

Recent HIPAA Amendments and Proposed Regulations

In the last year, two significant HIPAA regulations were issued, impacting employer group health plans. This article summarizes the new rules – one under the privacy rule provisions and one under the security rule provisions – and what employers need to know about the current legal status of these rules and how to prepare for […]
Read more
March 28, 2025
FMLA

Navigating Employer Leave under Federal FMLA and State Family and Medical Leave Programs

Employers are increasingly faced with the challenge of managing time-off policies amid a complex web of state, local, and federal laws – specifically the interplay between state paid family and medical leave (PFML) programs and the federal Family and Medical Leave Act (FMLA). An opinion letter issued by the U.S. Department of Labor’s (DOL) Wage […]
Read more
March 27, 2025
Affordable Care Act (PPACA)

Reporting Rules Ease Employer ACA Compliance Obligations

Two new federal laws passed at the end of 2024 bring welcomed updates to benefit plan sponsors. Under the Employer Reporting Improvement Act (ERIA) and the Paperwork Burden Reduction Act (PBRA) plan sponsors are no longer required to distribute Forms 1095-B and 1095-C to all covered individuals. The laws also offer employers new protections related […]
Read more